Fisher & Paykel Healthcare

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

MACD Volume

Score

0.35

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 38 9.9 0.55% 1.17% 3.5% -2.7% 25.4%
SHORT 38 10.3 0.37% 0.58% 3.1% -2.0% -4.1%

Summary

Technical Analysis

Fisher & Paykel Healthcare (FPH.AX)


Indicator:

VOLUME MACD


Last Signal:

BEARISH


Trading: SELL @ $15.13
Signal Strength: MEDIUM
Recommendation:

Fisher & Paykel Healthcare (ASX:FPH) currently has negative Volume MACD of -27585. This means the signal line is less than the Volume MACD line signalling a bearish movement.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


Volume Moving Average Convergence/Divergence (VMACD) is an indicator that shows the relationship between two moving averages. It is calculated as a difference between the fast and slow moving averages. The historically popular is the difference between a securities 26-day and 12-day Exponential Moving Averages (EMA).

Calculation: Moving Average Convergence Divergence Volume (VMACD):
1) VMACD Line: (12-day EMA - 26-day EMA);
2) Signal Line: 9-day EMA of VMACD Line;
3) VMACD Histogram: VMACD Line - Signal Line;


PROFILE: Fisher & Paykel Healthcare (FPH.AX)


Stock Exchange: ASX
Company: Fisher & Paykel Healthcare
Ticker Codes: | FPH.AX | ASX:FPH |

About Fisher & Paykel Healthcare (ASX:FPH):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Top 10:

MACD Volume

Download
Company Close Change(%) Volume Value Signal
EWC Energy World Corporation 0.08 11 792,083 -78,398 BEARISH
BNO Bionomics 0.04 7.5 133,061 -335,768 BEARISH
AYS Amaysim Australia 0.78 5.4 268,838 -7,086 BEARISH
SXY Senex Energy 0.36 4.4 3,369,730 -688,138 BEARISH
MRN Macquarie Radio Network 1.85 4.2 1,000 -25 BEARISH
BSE BSE 0.25 4.2 720,251 -108,632 BEARISH
CLQ Clean Teq Holdings 0.37 4.2 1,734,161 -42,153 BEARISH
MVF Monash IVF 1.44 3.6 383,757 -74,105 BEARISH
ONT 1300 Smiles 6.4 3.6 782 -770 BEARISH
BAF Blue Sky Alternatives 0.77 3.4 87,323 -24,091 BEARISH